Global Oral Antidiabetic Drugs Market Status and Outlook 2018-2025

August 2018 | 136 pages | ID: GAEFDE5BC61EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Eli Lilly
• Merck
• Pfizer
• Abbott
• Biocon
• Sanofi
• Sunpharma
• Novartis
• Novo Nordisk
• Boehringer Ingelheim
• Takeda Pharmaceuticals
• Oramed Pharmaceuticals
• Jiangsu Wanbang
• Nanjing Xinbai

Market by Type

• Sulfonylureas
• Biguanides
• Meglitinides
• Alpha-glucosidase Inhibitors
• Others

Market by Application

• Hospitals
• Clinics
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Oral Antidiabetic Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Sulfonylureas
  3.1.2 Biguanides
  3.1.3 Meglitinides
  3.1.4 Alpha-glucosidase Inhibitors
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospitals
  4.1.2 Clinics
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Sulfonylureas Production by Region
    6.1.1.2 Biguanides Production by Region
    6.1.1.3 Meglitinides Production by Region
    6.1.1.4 Alpha-glucosidase Inhibitors Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospitals Production by Region
    6.1.2.2 Clinics Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Sulfonylureas Demand by Region
    6.2.1.2 Biguanides Demand by Region
    6.2.1.3 Meglitinides Demand by Region
    6.2.1.4 Alpha-glucosidase Inhibitors Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospitals Demand by Region
    6.2.2.2 Clinics Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Eli Lilly
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merck
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Pfizer
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Abbott
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Biocon
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Sanofi
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Sunpharma
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Novartis
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Novo Nordisk
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Boehringer Ingelheim
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Takeda Pharmaceuticals
8.12 Oramed Pharmaceuticals
8.13 Jiangsu Wanbang
8.14 Nanjing Xinbai

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Oral Antidiabetic Drugs Industry Dynamics & Regulations List
Table Global Oral Antidiabetic Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Oral Antidiabetic Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Oral Antidiabetic Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Oral Antidiabetic Drugs Market Status by Application 2015-2018E, in Volume
Table Global Oral Antidiabetic Drugs Market by Region 2015-2018E, in USD Million
Table Global Oral Antidiabetic Drugs Market Share by Region in 2018, in USD Million
Table Global Oral Antidiabetic Drugs Market by Region 2015-2018E, in Volume
Table Global Oral Antidiabetic Drugs Market Share by Region in 2018, in Volume
Table Sulfonylureas Production Value by Region 2015-2018E, in USD Million
Table Sulfonylureas Production Volume by Region 2015-2018E, in Volume
Table Biguanides Production Value by Region 2015-2018E, in USD Million
Table Biguanides Production Volume by Region 2015-2018E, in Volume
Table Meglitinides Production Value by Region 2015-2018E, in USD Million
Table Meglitinides Production Volume by Region 2015-2018E, in Volume
Table Alpha-glucosidase Inhibitors Production Value by Region 2015-2018E, in USD Million
Table Alpha-glucosidase Inhibitors Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospitals Production Value by Region 2015-2018E, in USD Million
Table Hospitals Production Volume by Region 2015-2018E, in Volume
Table Clinics Production Value by Region 2015-2018E, in USD Million
Table Clinics Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Sulfonylureas Market Size by Region 2015-2018E, in USD Million
Table Sulfonylureas Market Size by Region 2015-2018E, in Volume
Table Biguanides Market Size by Region 2015-2018E, in USD Million
Table Biguanides Market Size by Region 2015-2018E, in Volume
Table Meglitinides Market Size by Region 2015-2018E, in USD Million
Table Meglitinides Market Size by Region 2015-2018E, in Volume
Table Alpha-glucosidase Inhibitors Market Size by Region 2015-2018E, in USD Million
Table Alpha-glucosidase Inhibitors Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospitals Market Size by Region 2015-2018E, in USD Million
Table Hospitals Market Size by Region 2015-2018E, in Volume
Table Clinics Market Size by Region 2015-2018E, in USD Million
Table Clinics Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalOral Antidiabetic Drugs Forecast by Type 2019F-2025F, in USD Million
Table Oral Antidiabetic Drugs Forecast by Type 2019F-2025F, in Volume
Table Oral Antidiabetic Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Oral Antidiabetic Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Oral Antidiabetic Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Oral Antidiabetic Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Eli Lilly Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Eli Lilly
Table Merck Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Merck
Table Pfizer Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Pfizer
Table Abbott Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Abbott
Table Biocon Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Biocon
Table Sanofi Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Sanofi
Table Sunpharma Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Sunpharma
Table Novartis Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Novartis
Table Novo Nordisk Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Novo Nordisk
Table Boehringer Ingelheim Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Boehringer Ingelheim
Table Takeda Pharmaceuticals Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Takeda Pharmaceuticals
Table Oramed Pharmaceuticals Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Oramed Pharmaceuticals
Table Jiangsu Wanbang Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Jiangsu Wanbang
Table Nanjing Xinbai Information
Table Oral Antidiabetic Drugs Sales, Cost, Margin of Nanjing Xinbai
Table Global Oral Antidiabetic Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Oral Antidiabetic Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Oral Antidiabetic Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Oral Antidiabetic Drugs Picture
Figure Oral Antidiabetic Drugs Industry Chain Diagram
Figure Global Oral Antidiabetic Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Oral Antidiabetic Drugs Sales Volume 2015-2018E, in Volume
Figure Global Oral Antidiabetic Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Oral Antidiabetic Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Oral Antidiabetic Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Oral Antidiabetic Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Oral Antidiabetic Drugs Sales Price Forecast 2019F-2025F
Figure Global Oral Antidiabetic Drugs Gross Margin Forecast 2019F-2025F
Figure Global Oral Antidiabetic Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Oral Antidiabetic Drugs Price by Company in 2018
Figure Global Oral Antidiabetic Drugs Gross Margin by Company in 2018